Medulloblastoma Recurrent Or Progressive clinical trials

Explore recruiting medulloblastoma recurrent or progressive clinical trials.

Recruiting medulloblastoma recurrent or progressive studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Medulloblastoma Recurrent Or Progressive trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I study of CDK8 inhibitor RVU120 in combination with everolimus in children with recurrent or progressive Group 3 or 4 medulloblastoma; MEDWAY

Poland

Human Pharmacology (Phase I)- Other EU CTIS Study details

Medulloblastoma Recurrent Or Progressive trials by city

Medulloblastoma Recurrent Or Progressive in Toronto Medulloblastoma Recurrent Or Progressive in Vancouver Medulloblastoma Recurrent Or Progressive in Montreal Medulloblastoma Recurrent Or Progressive in Calgary Medulloblastoma Recurrent Or Progressive in Edmonton Medulloblastoma Recurrent Or Progressive in Ottawa Medulloblastoma Recurrent Or Progressive in Winnipeg Medulloblastoma Recurrent Or Progressive in Quebec City Medulloblastoma Recurrent Or Progressive in Hamilton Medulloblastoma Recurrent Or Progressive in Kitchener Medulloblastoma Recurrent Or Progressive in London Medulloblastoma Recurrent Or Progressive in Halifax Medulloblastoma Recurrent Or Progressive in New York Medulloblastoma Recurrent Or Progressive in Los Angeles Medulloblastoma Recurrent Or Progressive in Chicago Medulloblastoma Recurrent Or Progressive in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease